ANTX
AN2 Therapeutics Inc
4.80$
-0.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
AN2 Therapeutics Inc (ANTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -7.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -17 | -18 | -14 | -12 | -5.3 | -11 | -7.6 | -6.4 | -5.2 | -12 | -7.0 | -31 | |
| – | 0.4 | 0.4 | – | – | – | – | – | – | – | – | – | – | |
| 2.2 | 2.2 | 2.4 | 2.3 | 1.9 | 1.8 | 2.0 | 2.0 | 0.8 | 1.4 | 1.5 | 1.0 | 4.6 | |
| 3.4 | -1.1 | -2.3 | -1.3 | -0.4 | 1.0 | -1.6 | -2.8 | 2.4 | 2.2 | -3.4 | -0.1 | 1.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -62 | 0.4 | 26 | 16 | 19 | -6.9 | 9.2 | 5.8 | 6.1 | 7.2 | 8.3 | -3.7 | 18 | |
| – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | |
| 66 | -0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 37 | 1.5 | 39 | |
| -8.2 | -17 | 9.0 | 2.1 | 6.7 | -12 | -1.4 | -1.8 | -0.2 | 1.9 | 34 | -9.2 | 26 | |
| -12 | -17 | -18 | -14 | -12 | -5.3 | -11 | -7.6 | -6.4 | -5.2 | -12 | -7.0 | -31 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.